Bintai Healthcare inks agreement with NGT Solutions


Bintai Kinden executive director Azri Azerai

KUALA LUMPUR: Bintai Kinden Corp Bhd’s subsidiary, Bintai Healthcare Sdn Bhd has signed a deal to expand its healthcare product offering and market footprint in Malaysia.

In a statement Tuesday, it said Bintai Healthcare had entered into a business collaboration agreement with NGT Solutions (M) Sdn Bhd (NGTS), an appointed healthcare organiser of Duopharma Biotech Bhd to jointly distribute Sinopharm’s Covid-19 vaccine to the private sector in Malaysia.

The Star Festive Promo: Get 35% OFF Digital Access

Monthly Plan

RM 13.90/month

Best Value

Annual Plan

RM 12.33/month

RM 8.02/month

Billed as RM 96.20 for the 1st year, RM 148 thereafter.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!

Next In Business News

Up in Arms - or up the value chain?
US LNG exporters lead in gas use
Ringgit closes higher against greenback on cautious market sentiment
T7 Global subsidiary appointed panel contractor for PETRONAS
YTL inks RM200mil naming rights deal with Aviva for Bristol arena
KL High Court dismisses appeals of former Jalatama officers
Well Chip posts FY25 net profit jump to RM86.15mil
Angkasa targets 2026 revenue to reach up to RM75bil
Aeon Credit issues RM100mil five-year senior sukuk
Late bargain-hunting lifts Bursa Malaysia to end higher

Others Also Read